Hypothesis

7 Matching Annotations

Jun 2026
www.sciencedirect.com www.sciencedirect.com

An orally active dual CBP/p300 degrader targets core dependencies of multiple myeloma

1
1. scibot 04 Jun 2026
  
  in Public
  
  RRID: CVCL_2030
  
  DOI: 10.1016/j.celrep.2026.117464
  
  Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)
  
  Curator: @nmaralla
  
  SciCrunch record: RRID:CVCL_2030
  
  What is this?
  
  RRID:CVCL_2030
Visit annotations in context

Tags

RRID:CVCL_2030

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124726005425
Jul 2024
www.sciencedirect.com www.sciencedirect.com

IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma

1
1. scibot 24 Jul 2024
  
  in Public
  
  CVCL_2030
  
  DOI: 10.1016/j.ccell.2024.05.026
  
  Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2030
  
  What is this?
  
  RRID:CVCL_2030
Visit annotations in context

Tags

RRID:CVCL_2030

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610824002174
May 2024
www.tandfonline.com www.tandfonline.com

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

1
1. scibot 26 May 2024
  
  in Public
  
  CVCL_2030
  
  DOI: 10.1080/15384047.2024.2314322
  
  Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2030
  
  What is this?
  
  RRID:CVCL_2030
Visit annotations in context

Tags

RRID:CVCL_2030

Annotators

scibot

URL

tandfonline.com/doi/abs/10.1080/15384047.2024.2314322
Feb 2024
www.biorxiv.org www.biorxiv.org

KDM6A Regulates Immune Response Genes in Multiple Myeloma

1
1. scibot 22 Feb 2024
  
  in Public
  
  RRID:CVCL_2030
  
  DOI: 10.1101/2024.02.12.579179
  
  Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)
  
  Curator: @mzhang007
  
  SciCrunch record: RRID:CVCL_2030
  
  What is this?
  
  RRID:CVCL_2030
Visit annotations in context

Tags

RRID:CVCL_2030

Annotators

scibot

URL

biorxiv.org/content/10.1101/2024.02.12.579179v1
Oct 2022
www.sciencedirect.com www.sciencedirect.com

High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity

1
1. scibot 05 Oct 2022
  
  in Public
  
  RRID:CVCL_2030
  
  DOI: 10.1016/j.immuni.2022.09.004
  
  Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_2030
  
  What is this?
  
  RRID:CVCL_2030
Visit annotations in context

Tags

RRID:CVCL_2030

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761322004988
May 2021
www.sciencedirect.com www.sciencedirect.com

Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption

1
1. scibot 09 May 2021
  
  in Public
  
  CVCL_2030
  
  DOI: 10.1016/j.stem.2020.12.017
  
  Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2030
  
  What is this?
  
  RRID:CVCL_2030
Visit annotations in context

Tags

RRID:CVCL_2030

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1934590920306019
Feb 2021
www.sciencedirect.com www.sciencedirect.com

Targeted degradation of the enhancer lysine acetyltransferases CBP and p300

1
1. scibot 24 Feb 2021
  
  in Public
  
  RRID: CVCL_2030
  
  DOI: 10.1016/j.chembiol.2020.12.004
  
  Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)
  
  Curator: @bandrow
  
  SciCrunch record: RRID:CVCL_2030
  
  What is this?
  
  RRID:CVCL_2030
Visit annotations in context

Tags

RRID:CVCL_2030

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945620305134